INTRODUCTION
Otitis media with effusion (OME) is a significant cause of childhood morbidity and developmental delay. 1, 2 There is enormous controversy regarding the efficacy of the various medical and surgical treatments of OME. There are a number of conflicting reports on the value of adenoidectomy or adenotonsillectomy in the management of OME. However, the vast majority of well-designed studies have shown it to be effective in selected group of children. 3 The role of adenoids in middle ear disease is complex. The removal of large adenoids results in better effusion resolution compared with removing smaller adenoids, suggesting that mechanical obstruction of the eustachian tube may be an important factor. 4 However, recurrent or chronic infection in the adenoids without obstructive hypertrophy may also manifest as recurrent AOM, persistent OME, or chronic rhinosinusitis, supporting the widely held theory of adenoids being a reservoir of pathogenic organisms leading to tubal edema and malfunction. 5 Although simultaneous adenoidectomy and myringotomy plus ventilation tube insertion (MVTI) is considered beneficial, adverse effect includes hemorrhage, infection, and velopalatine insufficiency. 6 Current pediatric otolaryngology textbooks 7, 8 recommend adenoidectomy and MVTI but not tonsillectomy in children with severe ear disease and those undergoing replacement of a second set of ventilation tubes.
The aims of this population-based study were to estimate and compare the incidence of undergoing subsequent MVTI procedures in children less than 10 years of age who had prior MVTI with and without adenoidectomy or tonsillectomy. Social and demographic factors associated with risk of undergoing further MVTI surgery and procedure complication rates were also investigated. Western Australia is the largest state of Australia, with a population of approximately 2 million, the majority of inhabitants residing in Perth, the only major metropolitan city. The Western Australian Data Linkage System (WADLS) was used to access all hospital separation data pertaining to all resident children less than 10 years of age spanning 24 years from 1981 to 2004.
MATERIALS AND METHODS
Study data were obtained from WADLS after University of Western Australia ethics and confidentiality clearance through the WA Safety and Quality of Surgical Care Project. 9 The WADLS is a validated, ongoing, dynamic data linkage system that creates links between administrative health data. These data include all hospital morbidity data, birth and death records, mental health services data, cancer registrations, and midwives' notifications of all Western Australians. 10 Procedures performed in day surgery clinics were also included in the hospital morbidity data system as a hospital admission. A de-identified extraction of all hospital morbidity records belonging to persons who underwent a MVTI procedure between January 1, 1981 and December 31, 2004 was performed. Demographic, diagnostic, and procedural data were included in the extraction. Before 1989, International Classification of Disease (ICD) coding did not distinguish between myringotomy alone and MVTI. With use of 1990 data as a guide, it was estimated that 5% of myringotomy procedures before 1989 did not have ventilation tube insertions. The potential of this misclassification to bias the findings of this study was assessed by restricting analysis to 1989 onward and comparing it with analysis of the full study. This restriction resulted in only minor changes to some odds ratio (OR) values, and there was no evidence that any study conclusions were affected (data not shown), and data from 1981 to 88 was therefore included in the analysis presented here.
The index admission was defined as the first hospital admission with an ICD procedure code for MVTI insertion while less than 10 years of age. There was no age restriction on the identification of subsequent MVTI surgery. Information on the type of ventilation tubes used was not available for this study. Pharyngeal surgery at time of MVTI surgery was defined as having ICD procedures codes for adenoidectomy, adenotonsillectomy, or tonsillectomy during the MVTI admission. A child was identified as having adenoid and or tonsil disease if ICD-9-CM diagnosis codes 474 and ICD-10 codes J35 were associated with the MVTI admission. Hemorrhage during the MVTI admission or any subsequent readmissions within 30 days of separation were identified. Children with chromosomal abnormalities, cleft palate, and other ear, nose, and facial congenital abnormalities were also identified. Procedures for the removal of ventilation tubes were not evaluated in this study.
Age at first MVTI was collapsed into two age groups, 0 to 3 years and 4 to 9 years. Residential location was defined as metropolitan Perth, rural, or remote. Hospitals were aggregated into a Health Service District based on their location. Where possible, Australian Bureau of Statistics (ABS) census collector's districts were used to assign one of four socioeconomic status levels using the Socioeconomic Index of Disadvantage compiled by the ABS of the closest census year to admission year; otherwise, post code of residence at index admission was used. Indigenous status was defined as being Aboriginal or Torres Strait Islander or not. Length of stay in days was defined as the number of nights spent in hospital during the index admission and ranged from 0 upward.
Chi-square tests were used to compare the overall proportion of children undergoing further MVTI surgery by type of first MVTI surgery. The Student's t test was used to compare mean length of stay in hospital by surgical procedure. Multivariate logistic regression was performed to identify procedural, demographic, social, and hospital factors associated with 1) having pharyngeal surgery at time of first or second MVTI, 2) having a subsequent second MVTI procedure, 3) hemorrhage during pharyngeal surgery, and 4) being readmitted within 30 days for hemorrhage. Plausible interaction terms were tested using the likelihood ratio test between models with and without the interaction term. Analysis for 2) was restricted to children who underwent surgery for first MVTI before 2001 to ensure a 4 year look-forward period for further surgery to occur. All multivariate analysis was adjusted for age, calendar period, residential location, socioeconomic status, indigenous status, hospital health service district, and chromosomal abnormalities, cleft palate and other ear, nose, and facial congenital abnormalities that predispose children to middle ear surgery. Ninety-five percent confidence intervals (CI) around estimated OR are presented in brackets. All statistical analysis was performed using Stata 9 (College Station, TX). 11
RESULTS
There were 51,373 children less than 10 years of age who underwent at least one MVTI in 1 of 66 Western Australian hospitals or day surgeries from 1981 to 2004. Summary demographic and procedural data are presented in Table I . Approximately 29% (14,841) of children had their first MVTI at the same time as adenoid or tonsil surgery. Of those who had additional pharyngeal surgery at first MVTI, 7.4% (1,096) had no record of tonsil or adenoid disease.
Overall, the proportion of pharyngeal surgery performed at first MVTI halved from 40% in the early 1980s to 21% in 1995 but increased again in more recent calen- Adenoidectomy was the most commonly performed pharyngeal surgery at first and second MVTI in children without any record of adenoid or tonsil disease (Fig. 2) . First MVTI performed with adenoidectomy dropped to almost nonexistent levels by the mid 1990s but increased to 5% of procedures from 1998 to 2002, followed by another declining trend. Adenotonsillectomy in the absence of adenoid or tonsil disease also increased steadily from 1998 onward. Adenoidectomy performed with second MVTI increased steadily from 1993 onward, whereas adenotonsillectomy followed a more variable trend.
Multivariate logistic regression was performed to identify factors that were associated with increased odds of pharyngeal surgery in the absence of adenoidal or tonsillar disease. Children aged 4 to 9 years were 2.5 (95% CI 2.2-2.9) times more likely to undergo pharyngeal surgery at first MVTI compared with younger children, whereas the odds of younger children undergoing pharyngeal surgery at second MVTI procedure were 18% (95% CI 9 -25) higher. Indigenous status was associated with reduced odds of pharyngeal surgery at first (OR 0.3, 95% CI 0.2-0.6) but not second (OR 1.0, 95% CI 0.5-20) MVTI. Increasing socioeconomic status was also associated with reduced odds of pharyngeal surgery at first MVTI (OR 0.92, 95% CI 0.87-0.96) but not at second MVTI. There were large geographical variations in the odds of pharyngeal surgery with MVTI in the absence of tonsillar or adenoidal disease, particularly at first MVTI. With use of the central metropolitan health service district as the reference group, the relative odds of pharyngeal surgery at first MVTI in other health service districts ranged from 1.8 (95% CI 1.2-2.9) to 357 (95% CI 159 -803). The geographic variation of the odds of pharyngeal surgery at second MVTI was less marked and ranged from 1.9 (95% CI 1.1-3.4) to 7.8 (95% CI 3.3-18.4) times more than the reference district.
Approximately a third (30%, n ϭ 15,230) of all children had more than one MVTI procedure, although this is likely to be an underestimate because of limited follow-up time for children who had their first MVTI close to the study censor date of December 2004. Further analysis on the pattern of subsequent MVTI surgery after first MVTI was therefore restricted to the 41,963 children who had their first MVTI procedure before 2001 to allow 4 years of follow-up time for further surgery to be identified. The proportion of children having a second MVTI procedure was 16% lower in children who had adenoidectomy (P Ͻ .001), 17% lower with adenotonsillectomy (P Ͻ .001), and 10% lower with tonsillectomy (P Ͻ .001) at time of first MVTI compared with children who had MVTI alone (Fig. 3A) . Likewise, the proportion of children requiring a third MVTI procedure was 15% lower in children who had first MVTI alone and second MVTI with adenoidectomy (P Ͻ .001) and 17% lower with adenotonsillectomy (P Ͻ .001) compared with children who had two MVTI procedures alone. There was no statistically significant difference between proportion of children who had two MVTI procedures alone and those who had second MVTI with tonsillectomy (P ϭ .147) and having a third MVTI procedure. Similar proportions were observed when analysis was restricted to children who had no record of any tonsil or adenoid disease at time of first MVTI (Fig. 3B) .
Multivariate logistic regression was performed to account for potential confounders in the relationship between type of first MVTI surgery and whether subsequent MVTI surgery was undertaken (Table II) . Overall, children who had an adenoidectomy at time of first MVTI were 39% less likely, children who had adenotonsillectomy were 42% less likely, and children who had tonsillectomy were 28% less likely to undergo further MVTI procedures compared with children who had their first MVTI alone. Other factors also identified as being associated with lower odds of subsequent MVTI surgery were older age at first MVTI (OR 0.58, 95% CI 0.56 -0.61), indigenous status (OR 0.79, 95% CI 0.68 -0.91), living in areas of increasing socioeconomic status (OR 0.95, 95% CI 0.94 -97), Odds ratios (OR) and 95% confidence intervals (CI) from multivariate logistic regression model that was also adjusted* for age at first MVTI, congenital abnormalities, year, socioeconomic status, indigenous status, sex, hospital and residential location, and presence of adenoid or tonsil disease.
having first MVTI in a more recent calendar year (OR 0.99, 95% CI 0.98 -1.00), and having adenoid or tonsil disease at first MVTI (OR 0.82, 95% CI 0.70 -0.96). Large variations in the odds of undergoing subsequent MVTI surgery by hospital health service district were also observed. Compared with hospitals located within the central Perth health service district, the odds of subsequent MVTI ranged from 51% (95% CI 3-120) higher in one health service district to 80% (95% CI 44 -93) lower in a directly neighboring health service district after adjusting for other variables.
A significant interaction between calendar year and type of first surgery was present, which indicated that the relative odds of a second MVTI procedure by the type of surgery at first MVTI changed over the study period. It was found that the odds of further MVTI surgery reduced 23% (95% CI 17-30) from 1981 to 2000 in children who had first MVTI alone, whereas the odds of further MVTI surgery after having any pharyngeal surgery at time of first surgery did not change over the study period. When the regression analysis was restricted to children who had first MVTI surgery in 2000, it was found that the odds of undergoing subsequent MVTI surgery was reduced up to 57% (95% CI: 23-76) in children who had adenoidectomy and 28% (95% CI: 13-40) with adenotonsillectomy compared with children who had MVTI alone. There was no difference in the odds of subsequent MVTI surgery between first MVTI alone and with tonsillectomy (P ϭ .35) in 2000.
The length of stay in hospital for MVTI and associated pharyngeal surgery decreased with more recent calendar periods. In 2004, there was no significant difference in the mean length of stay in hospital of 0.17 days for MVTI alone and 0.15 days for MVTI with adenoidectomy (P ϭ .814). In contrast, MVTI surgery involving adenotonsillectomy or tonsillectomy in 2004 both resulted in mean hospital stays of 1.0 day, both significantly longer than for MVTI alone (P Ͻ .001).
Hemorrhage was the most commonly identified procedural complication for MVTI performed with adenoidectomy, adenotonsillectomy, and tonsillectomy alike both during the index admission and for readmissions within 30 days (Table III) . There were no recorded cases of hemorrhage associated with MVTI alone over the study period. After adjusting for the presence of congenital abnormalities and adenoid or tonsil disease, the odds of hemorrhage after MVTI with adenotonsillectomy was 2.2 (95% CI 1.3-3.7) times more likely during the index admission and 12.5 (95% CI 6.3-24.8) times more likely to result in readmission within 30 days compared with MVTI with adenoidectomy as the baseline. Similarly, the odds of hemorrhage after MVTI with tonsillectomy was 7.2 (95% CI 2.2-23.4) times more likely result in readmission within 30 days compared with MVTI with adenoidectomy, although, because of very small numbers, no increased association was found for index admissions. The odds of hemorrhage during the index admission or 30 day readmission were not associated with any other demographic, social, or hospitalrelated variables.
DISCUSSION
This large population based study has shown that having adenoidectomy or adenotonsillectomy at time of first or subsequent MVTI surgery was associated with reduced risk of further MVTI surgery. With the advantages of using hospital morbidity data collected at a population level over many years include statistical power and the ability to follow patients longitudinally and without the sometimes restrictive selection criteria required for clinical trials, the results can be generalized to the whole community. However, there are important limitations in this type of study to consider. The administrative data were not collected specifically to address the research questions and lacked a degree of diagnostic and clinical detail that may have led, for example, to an underestimation of the level of underlying tonsil/adenoid disease or the true procedural hemorrhage rate. In addition, the inability to identify the types of ventilation tubes used restricted our interpretation of the improved re-insertion rate observed for MVTI alone in more recent calendar periods. The quality of data coding is likely to have fluctuated over time with changes in individual hospital coding guidelines and lag periods between the introduction of a new technology and ICD codes that described it. Despite these limitations, identification of definitive surgical procedures and patient outcomes (such as 30 day readmissions) are a useful surrogate of finer clinical detail that, when applied at the population level, can provide a strong basis for research conclusions.
Additional pharyngeal surgery was performed frequently with first MVTI during the 1980s followed by a decline through the 1990s and is currently on the increase again. We believe this practice was encouraged by the increasing evidence in the literature in favor of additional pharyngeal surgery in the management of recurrent OME, Children with congenital facial abnormalities or Down's syndrome were excluded from this analysis (n ϭ 476). A ϭ adenoidectomy, AT ϭ adenotonsillectomy and T ϭ tonsillectomy.
especially in children with potential eustachian tube dysfunction secondary to adenoidal or tonsillar disease. Because of surgical risks, adenoidectomy in the absence of adenoid disease is not currently recommended for initial surgery for OME 12 despite evidence that adenoidectomy with or without myringotomy reduces the risk of requiring further MVTI surgery. 13, 14 We found that a significant proportion of children had their adenoids or tonsils out at first or second MVTI for persistent OME as a sole indication with no evidence of pharyngeal disease, which reflects the growing awareness of the otolaryngologist in targeting the underlying etiology. However, the large geographic variations in the practice of pharyngeal surgery at both first and second MVTI indicate a disparity of practice preference among otolaryngologists regarding treatment of OME. Some of this variation can be explained by unwillingness of otolaryngologists visiting regional and remote centers to perform a procedure with risk of postoperative hemorrhage in areas with reduced access to health care services. We expect a further increase in the rate of additional pharyngeal surgery in children failing the first MVTI in the presence or absence of adenoidal or tonsillar infection in the future.
There does appear to be a general reluctance to perform additional pharyngeal surgery at time of MVTI in indigenous children of any age. Although the difficulties of delivering specialist services to remote areas may account for reduced access to pharyngeal surgery for some indigenous children, those indigenous children living metropolitan areas were also less likely than the nonindigenous children to undergo additional pharyngeal surgery. These results appear contradictory with the high rates of OME reported in young indigenous children; 15 however, the etiology of middle ear disease in these children often involves different pathogens, 16 and further study is needed to clarify whether this difference is the result of access issues.
Adenoidectomy is now often performed as a same-day procedure. This change has made adenoidectomy with MVTI more acceptable both by the parents and service providers. The morbidity associated with adenoidectomy such as postoperative hemorrhage is minimal in comparison with procedures involving tonsils. On the basis of general results reported here, we approximate that for every 10,000 children with no evidence of adenoid or tonsil disease, 1,100 may be saved further MVTI surgery if they have adenoidectomy at time of first MVTI, and 187 hospital bed days will become available. It is expected that 27 children will experience hemorrhage during the procedure and 12 will be readmitted for hemorrhage within 30 days. Although a similar scenario for adenotonsillectomy means 1,700 children are saved further MVTI surgery, 67 children will experience hemorrhage during the procedure, 145 will be readmitted within 30 days with procedural hemorrhage, and an additional 1,173 hospital bed days would be required compared with undergoing two MVTI procedures. Tonsillectomy alone with MVTI was not associated with reduced risk of further MVTI surgery in recent calendar period, and, in consideration that that posttonsillectomy risk of hemorrhage remains a significant morbidity, tonsillectomy with MVTI cannot be supported in the absence of tonsil disease.
The increased cost of performing MVTI with adenoidectomy compared with MVTI alone is likely to influence surgical practice. The combined surgeon, anesthetic, and hospital facility expenses for MVTI with adenoidectomy in WA are estimated to average approximately $A1,500 to $A2,000 per procedure compared with $A1,300 to $A1,600 for MVTI alone. On the basis of these estimates alone, there is the potential for MVTI with adenoidectomy in the absence of adenoid disease to be a cost-effective measure, particularly if the parental costs of taking time from work to care for a child with ongoing OME requiring repeat surgery are taken into account. However, a detailed economic review to estimate the costs involved with the increased likelihood of children experiencing complications or readmissions remains to be conducted.
Overall, our data suggest that the addition of adenoidectomy reduces the need for ventilation tube reinsertions. This raises the possibility of advocating adenoidectomy at first MVTI as a possibly cost-effective, low-risk procedure to reduce the community cost of repeated MVTI. Adenoidectomy performed at first MVTI, particularly if high-risk target groups could be identified, would have the advantage of removing a potential cause of eustachian tube dysfunction, thereby reducing a child's risk of re-exposure to the hospital system and improving overall health outcomes. Further research in this area would appear justified to further clarify guidelines for management of OME.
